Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Vascular Pharmacology is Scopus-indexed (Q2, CiteScore 6.5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 1537-1891Verify ISSN ↗1879-3649Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: About US$3,670 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Physiology | 53 / 196 | 73rd | Q2 |
| Pharmacology | 90 / 328 | 72nd | Q2 |
| Molecular Medicine | 70 / 179 | 61st | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present, best quartile Q2, CiteScore 6.5.
Vascular Pharmacology is Q2 in Physiology (rank 53 of 196), Q2 in Pharmacology (rank 90 of 328) and Q2 in Molecular Medicine (rank 70 of 179), by CiteScore 2025.
Vascular Pharmacology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.5, which places it in quartile Q2 at the 73rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.990, quartile Q2, with an H-index of 114.
The publisher lists an article processing charge of about US$3,670 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Vascular Pharmacology is published by Elsevier Inc. Its print ISSN is 1537-1891 and its online ISSN is 1879-3649.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Vascular Pharmacology has an h-index of 104 and a 2-year mean of 2.22 citations per paper (OpenAlex). Its Scopus CiteScore is 6.5, quartile Q2. On 2-year citations it ranks #111 of 194 Scopus journals in Physiology.
Vascular Pharmacology published 91 papers in 2025; its busiest recent year was 2018 with 187. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2025–2026), authors are most often from Italy (43.2%), China (15.1%) and United States (13.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (1.2 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.